| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |